News

Scientists have published findings of their research into how two important antibody drugs, rituximab and obinutuzumab, work and why they are sometimes ineffective in subsets of patients.

Scientists have outlined a new paradigm to explain the activation of Type II receptors. These receptors play important roles in our body’s use of cholesterol and glucose, among other critical processes.

A new study published in BMJ Open reveals that few pharmaceutical companies are fully transparent about the data behind the products they develop.

Researchers have used insulin-producing beta cells made from human stem cells to design an implant that senses and regulates blood glucose levels by responding with the correct amount of insulin.

Unlike routine blood tests for cholesterol and hormone levels, there’s no easy way to precisely measure a person’s individual circadian rhythm. That might just be set to change.

The thalamus is the relay station of sensory and motor abilities in the brain. Research has found that cells from the thalamus integrate information before sending it on.

Scientists have leveraged two new drug molecules, one of which is currently being tested in cancer clinical trials, to create a dual-drug therapy for alcohol use disorder, while avoiding side effects associated with existing treatment regimens.

Treating obese mice with a cytokine called TSLP, led to significant abdominal fat and weight loss compared to controls, according to new research.

A combination of cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would typically be considered for surgery.

The spike protein is found on the surface of SARS-CoV-2 and is responsible for its entry into host cells. Because of this function, it is the focus of most COVID-19 vaccines. A study has revealed foundational characteristics of the spike protein.